|
1.Anthony S., W. David, R. James, E. Delia, N. Marcel, W. Fred, Y. Albert, and T. Tai-Lan. 1994. Human endothelial cells are defective in diabetic vascular disease. J. Surg. Res. 57: 647-653. 2.Sowers, J. R., and M. Epstein. 1995. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy: An update. Hypertension 26: 869-879. 3.Friedman E. A. 1999. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. Diabetes Care 22(suppl. 2): B65-B71. 4.Pyorala K. 1990. Diabetes and coronary artery disease: what a coincidence? J. Cardiovasc. Pharmacol. 16(suppl. 9): S8-S14. 5.Tsao P. S., J. Niebanor, R. Buitrago, P. S. Lin, B. Y. Wang, J. P. Cooke, Y. D. I. Chen, and G. M. Reaven. 1998. Interaction of diabetes and hypertension on determinants of endothelial adhesiveness. Arterioscler. Thromb. Vasc. Biol. 18: 947-953. 6.Vischer U. M. 1999. Hyperglycemia and the pathogenesis of atherosclerosis: lessons from murine models. Euro. J. Endocrinol. 140: 1-3. 7.Jessup W., and L. Kritharides. 2000. Metabolism of oxidized LDL by macrophages. Curr. Opin. Lipidol. 11: 473-481. 8.Calles-Escandon J., E. Garcia-Rubi, S. Mirza, and A. Mortensen. 1999. Type 2 diabetes: one disease, multiple cardiovascular risk factors. Coronary Artery Dis. 10: 23-30. 9.Hayden J. M., and P. D. Reaven. 2000. Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors. Curr. Opin. Lipidol. 11: 519-528. 10. Ross R. 1993. The pathogenesis of atherosclerosis: a perspective of the 1990s. Nature. 362: 801-809. 11. Berg T. J., H. J. Bangstad, P. A. Torjesen, R. Qsterby, R. Bucala, and K. F. Hanssen. 1997. Advenced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent fiabetes mellitus. Metabolism 46: 661-665. 12. Cerami A., H. Vlassara, and M. Brownlee. 1987. Glucose and aging. Sci. Am. 256: 90-96. 13. Cerami A., H. Vlassara, and M. Brownlee. 1988. Role of advanced glycosylation products in complications of diabetes. Diabetes Care 11(suppl. 1): B73-B79. 14. Brownlee M. 1994. Glycation and diabetic complication. Diabetes 43: 836-841. 15. Wahab N. A., K. Harper, and M. Mason. 1996. Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia. Biochem. J. 316: 985-992. 16. Salameh A., M. Zinn, and S. Dhein. 1997. High D-glucose induces alterations of endothelial cell structure in a cell-culture model. J. Cardiovasc. Pharmacol. 30: 182-190. 17. Zhang J., S. Ren, D. Sun, and G. X. Shen. 1998. Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 18: 1140-1148. 18. Litwak K. N., W. T. Cefalu, and J. D. Wagner. 1998. Chronic hyperglycemia increases arterial low-density lipoprotein metabolism and atherosclerosis in cynomolgus monkeys. Metabolism 147: 947-954. 19. Proctor S.D., C. K. Pabla, and J. C. L. Mamo. 2000. Arterial intimal retention of pro-atherogenic lipoproteins in insulin deficient rabbits and rats. Atherosclerosis 149: 315-322. 20. Wautier J. L., C. Zoukourian, O. Chappey, M. P. Wautier, P. J. Guillausseau, R. Cao, O. Hori, D. Stern, and A. M. Schmidt. 1996. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. J. Clin. Invest. 97: 238-243. 21. Bonnardel-Phu E., J. L. Wautier, A. M. Schmidt, C. Avila, and E. Vicaut. 1999. Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo. Diabetes 48: 2052-2058. 22. Grundy S. M. 1995. Role of low-density lipoproteins in atherogenesis and development of coronary heart disease. Clin. Chem. 41: 139-146. 23. Kao C. H., J, K. Chen, and V. C. Yang. 1994. Ultrastructure and permeability of endothelial cells in branched regions of rat arteries. Atherosclerosis 105: 47-55. 24. Kao C. H., J, K. Chen, J. S. Kuo, and V. C. Yang. 1995. Visualization of the transport pathways of low density lipoproteins across the endothelial cells in the branched regions of rat arteries. Atherosclerosis 116: 27-41. 25. Lee W. C., W. T. Chao, and V. C. Yang. 2001. Effects of high-cholesterol diet on the interendothelial clefts and the associated junctional complexes in rat aorta. Atherosclerosis. 155: 307-312. 26. Way K. J., and J. J. Reid. 1995. Effect of diabetes and elevated glucose on nitric oxide-mediated neurotransmission in rat anococcygeus muscle. Br. J. Pharmacol. 115: 409-414. 27. Tanaka Y., H. Shimizu, N. Sato, M. Mori, and Y. Shimomura. 1995. Involvement of spontaneous nitiric oxide production in the diabetogenic action of streptozocin. Pharmacology 50: 69-73. 28. Janicki, P. K., J. L. Horn, G. Singh, V. E. Janson, W. T. Franks, and J.J. Franks. 1995. Reduced anesthetic requirements, diminished brain plasma membrane phospholipid methylation in diabetic rats: effects of insulin. Life Sci. 56: 357-364. 29. Makita Z., H. Vlassara, E. Rayfield, K. Cartwright, E. Friedman, R. Rodby, A. Cerami, and R. Bucala. 1992. Hemoglobin-AGE: a circulating maker of advanced glycosylation. Science 258: 651-653. 30. Havel R. J., H. A. Eder, and J. H. Bradgon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1352. 31. Handley D. A., C. M. Arbeeny, L. D. Witte, and S. Chien. 1981. Colloidal gold-low density lipoprotein conjugates as membrane receptor probes. Proc. Natl. Acad. Sci. USA. 78: 368-373. 32. Nistor A., and M. Simionescu. 1986. Uptake of low density lipoproteins by the hamster lung: interactions with capillary endothelium. Am. Rev. Respir. Dis. 134: 1266-1278. 33. Singh R., A. Barden, T. Mori, and L. Beilin. 2001. Advanced glycation end-products: a review. Diabetologia 44: 129-146. 34. Inouye M., T. Mio, and K. Sumino. 1999. Glycated hemoglobin and lipid peroxidation in erythrocytes of diabetic patients. Metabolism 48: 205-209. 35. Gerrity R. G., M. Richardson, J. B. Somer, F. P. Bell, and C. J. Schwartz. 1977. Endothelial cell morphology in areas of in vivo Evans blue uptake in the aorta of young pigs. Am. J. Pathol. 89: 313-334. 36. Zimmerman M., and J. McGeachie. 1986. Quantitation of the relationship between aortic endothelial intercellular cleft morphology and permeability to albumin. Atherosclerosis 59: 277-282. 37. Yang V. C., T. Y. Lee, G. Y. Hwang, C. H. Kao, and J. K. Chen. 1999. Immunolocalization of high-density lipoproteins in arterial walls of rats. Atherosclerosis 142: 269-277. 38. Yang V. V., P. J. O’Morchoe, and C. C. C. O’Morchoe. 1981. Transport of protein across lymphatic endothelium in the rat kidney. Microvasc. Res. 21: 75-91. 39. Park L., K. G. Ramam, K. J. Lee, Y. Lu, L. J. Ferran, W. S. Chow, D. Stern, and A. M. Schmidt. 1999. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat. Med. 4: 1025-1031 40. Schmidt A. M., S. D. Yan, J. L. Wautier, and D. Stern. 1999. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ. Res. 84: 489-497. 41. Markle R. A., and D. K. Walker. 1996. Effects of streptozotocin-induced diabetes and insulin treatment on substance P of the rat arterial wall. Life Sci. 58: 1123-1129 42. Like A. A., and A. A. Rossini. 1976. Streptozotocin-induced pancreatic insulitis: a new model of diabetes mellitus. Science 193: 415-417. 43. Elsner M., B. Guldbakke, M. Tiedge, R. Munday, and S. Lenzen. 2000. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of strptozotocin. Diabetologia 43: 1528-1533 44. Kunjathoor V. V., D. L. Wilson, and R. C. LeBoeuf. 1996. Increased atherosclerosis in streptozotocin-induced diabetic mice. J. Clin. Invest. 97: 1767-1773. 45. Chen Y. L., K. M. Jan, H. S. Lin, S. Chien. 1997. Relationship between endothelial cell turnover and permeability to horseradish peroxidase. Atherosclerosis 133: 7-14.
|